Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation

被引:26
|
作者
Yamakawa, Kazuma [1 ]
Umemura, Yutaka [2 ]
Murao, Shuhei [1 ]
Hayakawa, Mineji [3 ]
Fujimi, Satoshi [1 ]
机构
[1] Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi Ku, 3-1-56 Bandai Higashi, Osaka 5588558, Japan
[2] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka, Japan
[3] Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Sapporo, Hokkaido, Japan
关键词
anticoagulants; coagulopathy; critically ill; diagnostic criteria; DIC; septic shock; NATIONWIDE MULTICENTER REGISTRY; CRITICALLY-ILL PATIENTS; HIGH-DOSE ANTITHROMBIN; DIAGNOSTIC-CRITERIA; EFFICACY; THROMBOSIS; SAFETY; SCORE;
D O I
10.1177/1076029619835055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Optimizing diagnostic criteria to detect specific patients likely to benefit from anticoagulants is warranted. A cutoff of 5 points for the International Society on Thrombosis and Haemostasis overt disseminated intravascular coagulation (DIC) scoring system was determined in the original article, but its validity was not evaluated. This study aimed to explore the optimal cutoff points of DIC scoring systems and evaluate the effectiveness of early intervention with anticoagulants. We used a nationwide retrospective registry of consecutive adult patients with sepsis in Japan to develop simulated survival data, assuming anticoagulants were conducted strictly according to each cutoff point. Estimated treatment effects of anticoagulants for in-hospital mortality and risk of bleeding were calculated by logistic regression analysis with inverse probability of treatment weighting using propensity scoring. Of 2663 patients with sepsis, 1247 patients received anticoagulants and 1416 none. The simulation model showed no increase in estimated mortality between 0 and 3 cutoff points, whereas at >= 4 cutoff points, mortality increased linearly. The estimated bleeding tended to decrease in accordance with the increase in cutoff points. The optimal cutoff for determining anticoagulant therapy may be 3 points to minimize nonsurvival with acceptable bleeding complications. The findings of the present study suggested a beneficial association of early intervention with anticoagulant therapy and mortality in the patients with sepsis-induced DIC. Present cutoff points of DIC scoring systems may be suboptimal for determining the start of anticoagulant therapy and delay its initiation.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Efficacy of viscoelastic hemostatic assay testing in patients with sepsis-induced disseminated intravascular coagulation
    Hu, Yue Lin
    McRae, Hannah L.
    Refaai, Majed A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (06) : 873 - 875
  • [42] Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH
    Iba, T.
    Levy, J. H.
    Wada, H.
    Thachil, J.
    Warkentin, T. E.
    Levi, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (02) : 415 - 419
  • [43] Recent advances in disseminated intravascular coagulation: Endothelial cells and fibrinolysis in sepsis-induced DIC
    Madoiwa S.
    Journal of Intensive Care, 3 (1)
  • [44] Clinical Investigation of Coagulation Markers for Early Detection of Sepsis-Induced Disseminated Intravascular Coagulation: A Single-Center, Prospective Observational Study
    Masuda, Takamitsu
    Shoko, Tomohisa
    Deguchi, Yoshizumi
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (07) : 1082 - 1087
  • [45] Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation
    Iba, Toshiaki
    Helms, Julie
    Neal, Matthew D.
    Levy, Jerrold H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (12) : 3360 - 3370
  • [46] ANTITHROMBIN SUPPLEMENTATION AND MORTALITY IN SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY
    Hayakawa, Mineji
    Kudo, Daisuke
    Saito, Shinjiro
    Uchino, Shigehiko
    Yamakawa, Kazuma
    Iizuka, Yusuke
    Sanui, Masamitsu
    Takimoto, Kohei
    Mayumi, Toshihiko
    Ono, Kota
    Azuhata, Takeo
    Ito, Fumihito
    Yoshihiro, Shodai
    Hayakawa, Katsura
    Nakashima, Tsuyoshi
    Ogura, Takayuki
    Noda, Eiichiro
    Nakamura, Yoshihiko
    Sekine, Ryosuke
    Yoshikawa, Yoshiaki
    Sekino, Motohiro
    Ueno, Keiko
    Okuda, Yuko
    Watanabe, Masayuki
    Tampo, Akihito
    Saito, Nobuyuki
    Kitai, Yuya
    Takahashi, Hiroki
    Kobayashi, Iwao
    Kondo, Yutaka
    Matsunaga, Wataru
    Nachi, Sho
    Miike, Toru
    Takahashi, Hiroshi
    Takauji, Shuhei
    Umakoshi, Kensuke
    Todaka, Takafumi
    Kodaira, Hiroshi
    Andoh, Kohkichi
    Kasai, Takehiko
    Iwashita, Yoshiaki
    Arai, Hideaki
    Murata, Masato
    Yamane, Masahiro
    Shiga, Kazuhiro
    Hori, Naoto
    SHOCK, 2016, 46 (06): : 623 - 631
  • [47] Pneumococcal Sepsis-induced Purpura Fulminans in an Asplenic Adult Patient Without Disseminated Intravascular Coagulation
    Saraceni, Christine
    Schwed-Lustgarten, Daniel
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (06): : 514 - 516
  • [48] Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation
    Kotake, Kazumasa
    Hongo, Takashi
    Tahira, Akihiro
    Niimi, Nana
    Haisa, Ikue
    Kawakami, Yasuhiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (05) : 605 - 610
  • [49] Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation
    Madoiwa, Seiji
    Nunomiya, Shin
    Ono, Tornoko
    Shintani, Yuichi
    Ohmori, Tsukasa
    Mimuro, Jun
    Sakata, Yoichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (05) : 398 - 405
  • [50] Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
    Akahoshi, Tomohiko
    Kaku, Noriyuki
    Shono, Yuji
    Yamamoto, Yuzo
    Takahashi, Keita
    Iyonaga, Takeshi
    Momii, Kenta
    Nishihara, Masaaki
    Maki, Jun
    Tokuda, Kentaro
    Yamaura, Ken
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28